Although there exist strong studies about the effects of GLP-1 RAs on stroke and MACE, more information is required to extrapolate these results to other neurological fields as they seem to be very poor and insufficient in the fields of cognitive impairment and peripheral neuropathy. The gene discussed is GLP1R; the disease is stroke disorder.